During the past decade, GCM Medical Group PSC conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 27 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 20 clinical trials were completed. i.e. 142.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "GCM Medical Group PSC" #1 sponsor was "Eli Lilly and Company" with 26 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "Vertex Pharmaceuticals Incorporated" with 2 trials sponsored, "Amgen" with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "GCM Medical Group PSC" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "GCM Medical Group PSC" are "Psoriasis" (6 trials), "Type 2 Diabetes Mellitus" (6 trials), "Diabetes Mellitus, Type 2" (4 trials), "Plaque Psoriasis" (3 trials) and "Atopic Dermatitis" (2 trials). Many other conditions were trialed in "GCM Medical Group PSC" in a lesser frequency.

Most popular intervention types in "GCM Medical Group PSC" are "Drug" (34 trials), "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (26 trials), "Ixekizumab" (6 trials), "Tirzepatide" (4 trials), "Baricitinib" (3 trials) and "Dulaglutide" (3 trials). Other intervention names were less common.

The vast majority of trials in "GCM Medical Group PSC" are 36 trials for "All" genders.

Currently, there are NaN active trials in "GCM Medical Group PSC". undefined are not yet recruiting, 2 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in GCM Medical Group PSC, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in GCM Medical Group PSC, 0 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 26 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".